Skip to content

A clinical study to evaluate the efficacy of oral administration of Nimbashatka choorna and Nimba malahara lepa with Vidangadi choorna and Nimba malahara lepa in itching per vagina.

A randomized open-labelled comparative clinical study to evaluate the efficacy of oral administration of Nimbashatka choorna and Nimba malahara lepa with Vidangadi choorna and Nimba malahara lepa in Acharana yonivyapat with special reference to pruritus vulvae - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071006
Enrollment
30
Registered
2024-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L292- Pruritus vulvae

Interventions

None listed

Sponsors

Dr Gopika P
Lead Sponsor
Sri Sri College of Ayurvedic Science and Research
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects irrespective of marital status 2) Subjects in perimenopausal and post-menopausal age group 3)Subjects diagnosed with classical symptoms of Acharana yonivyapath 4)Subjects with classical symptoms of Pruritus vulvae. 5)Subjects willing to sign the consent form

Exclusion criteria

Exclusion criteria: 1.Subjects who are pregnant and lactating mothers. 2.Subjects during the time of menstruation. 3.Subjects with uncontrolled diabetes mellitus. 4.Subject with known case of sexually transmitted diseases. 5.Subject with known case of benign and malignant conditions. 6.Subject with known case of systemic disorders.

Design outcomes

Primary

MeasureTime frame
There is significant decrease in Pruritus vulvae which will be assessed based on 5-D Pruritus scaleTimepoint: Pre assessment 0th day 1st assessment On 7th day Follow up On 15th day

Secondary

MeasureTime frame
Generation of in-depth analysis of duration, degree, direction, disability & distribution of Pruritus vulvae Generation of data on possible unexpected drug reaction. Timepoint: 0th day to 15th day

Countries

India

Contacts

Public ContactDr Gopika P

Sri Sri College of Ayurvedic Science and Research

dr.rachanabhat@gmail.com9535744077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026